Clinical Expertise at Aspire for Wellness Together
Aspire for Wellness Together is led by Sandra Mannon, DNP, APRN , a family nurse practitioner whose healthcare career began in 1992. Her clinical background includes 20 years in critical care, followed by advanced practice nursing and functional medicine. Dr. Mannon also has extensive experience in healthcare education, including 10 years as adjunct faculty teaching senior nurse practitioner students. Her approach emphasizes individualized care, patient education, and long-term health and wellness.
You're tired, unfocused, and wondering whether changing your hormones could help. Maybe you've already tried to manage symptoms with daily medication, topical products, or lifestyle changes, and the idea of a treatment that works consistently for months sounds appealing. Before deciding, it helps to understand the full trade-off, especially the difference between convenience and reversibility.
Hormone pellets can provide prolonged hormone delivery, but they also create a commitment that's harder to undo than a patch, gel, cream, or oral medication. This guide explains the hormone pellets pros and cons in plain language, including who may be a candidate, what monitoring involves, and what can happen when the dose is higher than intended.
Table of Contents
- What Are Hormone Pellets
- The Main Benefits of Pellet Therapy
- Understanding the Risks and Downsides
- Comparing Pellets to Other HRT Options
- Who Should Consider Pellet Therapy
- Monitoring and Follow-Up Requirements
- Common Questions About Pellet Therapy
What Are Hormone Pellets
Hormone pellets are small, solid implants placed beneath the skin, usually in subcutaneous tissue. They're often described as being about the size of a grain of rice. A clinician makes a small incision, places the pellet under the skin, and closes the site with appropriate wound care.
The pellet gradually releases a hormone, commonly testosterone or estradiol, into the surrounding tissue and bloodstream. Unlike a daily pill or topical product, the patient doesn't need to remember each dose. The delivery is designed to continue over several months, although the exact duration and hormone exposure can vary between individuals.

Some pellets are described as bioidentical, meaning the hormone has the same molecular structure as a hormone produced naturally by the body. That description refers to the molecule, not to the safety of the dose, the delivery system, or the quality of the evidence. “Bioidentical” doesn't automatically mean a treatment is safer or more appropriate.
You can learn more about the procedure and treatment approach through hormone pellet therapy information from Aspire for Wellness Together. The important starting point is diagnostic clarity. A pellet shouldn't be used just because someone feels tired, has brain fog, or wants help with weight or aging concerns. Symptoms can have many possible contributors, including sleep problems, medication effects, nutritional issues, mood disorders, metabolic concerns, and other medical conditions.
The Main Benefits of Pellet Therapy
The strongest practical argument for pellets is adherence. A person who struggles to remember daily applications or repeated doses may prefer one procedure followed by a period without routine administration. Prolonged delivery can also appeal to people who dislike the fluctuations they associate with shorter-acting treatment.
A steady release may provide a more consistent exposure than a treatment that is taken irregularly. That doesn't guarantee better symptom relief, and it doesn't establish that pellets are superior to approved alternatives. It explains why some patients consider the format worth discussing.

Convenience has a clinical trade-off
A large retrospective analysis published in 2021 evaluated 1,204,012 testosterone and estradiol pellet-insertion procedures, one of the largest available datasets on procedural safety. It reported complications in approximately 1% of procedures overall, with a 93.3% continuation rate after two pellet insertions. Continuation was 89.2% among men and 94.3% among women. These findings show why many patients and clinicians view the procedure as generally tolerable, but they don't prove that pellets are safer or more effective than every other hormone-delivery method. The retrospective pellet safety analysis also has limitations, including its association with a pellet-treatment practice and the possibility that its findings may not apply to every setting.
The same analysis recorded local complications that were uncommon overall. Pellet extrusion occurred in 2.58% of male procedures and 0.356% of female procedures, while cellulitis or infection occurred in 0.412% and 0.028%, respectively. Operative-site bleeding was reported at approximately 0.1%. These are meaningful risks even when the recorded rates are low.
Practical rule: The benefit of fewer dosing decisions is real, but it shouldn't be separated from the fact that the dose becomes difficult to change once the pellet is in place.
That distinction is central. A person may value not having to remember a daily treatment, yet the same feature that improves convenience can make side effects more difficult to manage. Pellets may suit someone who values sustained delivery and accepts the monitoring and procedural commitment. They may be a poor fit for someone who wants to test a low dose, make frequent adjustments, or stop treatment quickly.
Understanding the Risks and Downsides
Pellets carry two broad categories of risk: procedure-related risks and hormone-exposure risks. The first category includes bleeding, infection, discomfort, and extrusion, which occurs when a pellet moves toward or through the skin. The second includes symptoms caused by an excessive or poorly tolerated hormone level.

The dose cannot be treated like a light switch
With a patch, gel, cream, or oral medication, a clinician can often reduce the dose or discontinue the treatment by changing or withholding the next administration. A pellet is different. It continues releasing hormone after insertion, and the patient can't remove it at home or skip the next dose to reverse an unwanted effect.
Testosterone exposure may cause acne, increased facial or body hair, hair loss, mood changes, weight gain, voice changes, or other androgen-related effects in susceptible patients. In women, some virilizing effects, such as voice deepening or clitoral enlargement, may be irreversible. A small 2025 study of women receiving testosterone pellets reported facial hair growth in 1 of 19 participants, or 5.3%, and vaginal bleeding in 2 of 19, or 10.5%. The sample was too small to establish rates for the broader population, but it illustrates why individualized dosing and follow-up matter. The clinical review of testosterone pellet risks describes these concerns alongside the challenge of correcting excessive exposure.
Men may face a different monitoring concern. In a 2018 study of men receiving subcutaneous testosterone pellets, secondary polycythemia developed in an estimated 10.4% by 6 months, 17.3% by 12 months, and 30.2% by 24 months. Polycythemia means an abnormal rise in red-blood-cell concentration, which can increase blood viscosity and may require evaluation, treatment interruption, or dose changes.
Compounded treatment adds another layer
The relevant question isn't only whether a hormone is chemically identical to one produced by the body. Patients should also ask how the product is prepared, how dosing is assessed, and what evidence supports the specific indication. The American College of Obstetricians and Gynecologists guidance on compounded menopausal hormone therapy advises against routinely prescribing compounded menopausal hormone therapy when FDA-approved alternatives exist. It also notes that no FDA-approved testosterone formulation is available for menopausal symptoms in the United States.
For women, long-term cardiovascular and breast-cancer risks of testosterone pellets remain uncertain because adequately powered randomized trials are lacking. The risk discussion should therefore include not only insertion complications, but also dose variability, limited evidence, monitoring access, and the consequences of an adverse effect that can't be rapidly reversed.
Comparing Pellets to Other HRT Options
A useful comparison starts with a practical question: How much control do you need after treatment begins? Pellets offer long-acting delivery and fewer administration decisions. Patches, gels, creams, and approved oral products generally offer more flexibility because the treatment can be adjusted or stopped without waiting for an implanted dose to dissipate.
No delivery method eliminates monitoring. The choice depends on the indication, medical history, symptoms, preferences, risk factors, cost, and willingness to undergo an insertion procedure. The quality of evidence for the specific hormone and symptom also matters.
HRT delivery methods compared
| Method | Dosing Frequency | Reversibility | Monitoring Burden |
|---|---|---|---|
| Pellets | Infrequent insertion over several months | Limited after insertion. Surgical removal may be considered when clinically necessary | Symptom review, hormone testing, blood-count monitoring, and assessment of insertion complications |
| Transdermal patches | Repeated application according to the prescribed product | Relatively flexible. The patch can be removed and future doses changed | Ongoing symptom and safety review, with laboratory testing when clinically appropriate |
| Topical gels or creams | Regular application according to the prescription | Relatively flexible. The next application can be withheld or adjusted | Symptom review, attention to application technique, and laboratory testing when appropriate |
| Injectable hormones | Repeated injections according to the medication and care plan | More adjustable than an implant, although the administered dose can't be taken back | Clinical follow-up and laboratory testing based on the hormone, indication, and patient risk |
The table shows why a “set it and forget it” approach can be misleading. The patient may forget the treatment day, but the clinician still needs a plan for baseline testing, follow-up testing, adverse effects, and future reinsertion decisions.
The Endocrine Society position on compounded bioidentical hormone therapy states that no clinical trial has established the safety or efficacy of compounded bioidentical hormone therapy. Compounded products also aren't subject to the same FDA oversight for dose, purity, safety, and effectiveness as approved products.
One observational cohort cited in the medical literature found bothersome side effects or adverse events in 57.6% of compounded-pellet users, compared with 14.8% of users of FDA-approved hormone products, over a mean 3.5-year follow-up. Pellet users more often reported anxiety, breast tenderness, acne, hair-pattern changes, weight gain, abnormal uterine bleeding, hysterectomy, and abnormal mammographic findings. Because the study was observational, it can't prove that pellets caused every difference, but it provides a safety signal that deserves discussion. The review of pellet therapy evidence and safety concerns places these results in the broader context of candidacy and surveillance.
Who Should Consider Pellet Therapy
Pellet therapy should begin with a clinical question, not a product preference. A provider should first determine whether symptoms are consistent with a hormone-related condition, whether testing supports the proposed treatment, and whether another explanation needs attention.
For men, guideline-based testosterone treatment includes screening for conditions that can increase risk. The Endocrine Society guideline for testosterone therapy recommends against treatment in men with breast or prostate cancer, a palpable prostate abnormality, an untreated severe sleep-breathing disorder, high hematocrit, uncontrolled heart failure, a heart attack or stroke within the previous 6 months, thrombophilia, or plans for near-term fertility.
Questions to answer before insertion
A careful evaluation should address:
- Symptoms and indication: What symptom or diagnosed condition is being treated, and what other causes have been considered?
- Medication review: Could a current prescription, supplement, or interaction be contributing to the problem?
- Laboratory findings: Which baseline measurements are needed, and how will the results affect candidacy?
- Cancer and bleeding history: Are breast, prostate, uterine, or other hormone-sensitive concerns present? Has unexplained vaginal bleeding been evaluated?
- Sleep and cardiovascular health: Is there untreated sleep apnea, high hematocrit, recent cardiovascular disease, or another contraindication?
- Fertility plans: Could testosterone treatment interfere with near-term fertility goals?
- Alternative delivery methods: Would a patch, gel, cream, injection, or approved oral product provide a safer or more adjustable starting point?
For men who choose prostate monitoring, clinicians should assess prostate-cancer risk before treatment and again 3 to 12 months afterward. Urologic evaluation is recommended if PSA rises by more than 1.4 ng/mL within 12 months, if confirmed PSA exceeds 4.0 ng/mL, or if a prostate abnormality is found on digital rectal examination. These thresholds are part of a structured safety process, not a reason to diagnose or treat based only on fatigue or reduced libido.
For women, the evidence supporting testosterone is strongest for carefully diagnosed hypoactive sexual desire disorder, not broad claims about energy, weight loss, cognition, or general “hormone balance.” Patients in Bradenton who are considering treatment can review the approach to individualized hormone replacement therapy for men while discussing whether the treatment is medically appropriate for their own history and goals.
Monitoring and Follow-Up Requirements
A pellet insertion isn't the end of care. It starts a period in which symptoms, hormone concentrations, blood counts, and other safety markers need to be reviewed. Patients should know before treatment who will order the tests, how results will be interpreted, and what happens if the dose is too high.
The Endocrine Society recommends checking testosterone concentrations 3 to 6 months after initiation and annually, with hematocrit measured before treatment, at 3 to 6 months, and yearly thereafter. The Endocrine Society monitoring guidance also identifies a hematocrit above 54% as a threshold for temporarily stopping therapy, evaluating causes such as hypoxia or sleep apnea, and restarting at a reduced dose when it's safe.

What monitoring should include
Before insertion, clinicians may review the indication, baseline hormone measurements, hematocrit, liver function, relevant cancer screening, medications, and risk factors. After insertion, follow-up should include more than a laboratory number. A patient may have a result that looks acceptable while experiencing acne, hair changes, bleeding, mood symptoms, or other clinically important effects.
A recent clinical review recommends checking testosterone, preferably with a high-quality LC-MS/MS method, along with hematocrit and liver function before treatment and again 3 to 6 months after insertion, with testing at each reinsertion. It recommends delaying reinsertion when testosterone remains excessively high, hematocrit exceeds approximately 48% to 50%, or clinically significant androgenic effects develop. The review addressing excessive pellet exposure and correction emphasizes the need to discuss thresholds and response plans before treatment begins.
“Bioidentical” describes chemical structure. It doesn't describe reversibility, dose accuracy, long-term safety, or the strength of clinical evidence. A responsible plan should spell out which symptoms require prompt contact, which results delay reinsertion, whether surgical removal might be considered, and when an adjustable formulation would be safer.
You can also review practical duration and follow-up considerations in how long hormone pellets last, then bring specific questions to your clinician rather than assuming the same schedule applies to everyone.
Common Questions About Pellet Therapy
Does insertion hurt?
The skin is numbed before the clinician makes the incision, but patients may still experience pressure, soreness, bruising, or swelling around the site. Aftercare depends on the location, closure method, and individual healing. Increasing redness, drainage, worsening pain, fever, or a pellet becoming visible through the skin should prompt timely clinical contact.
How long do pellets last?
Pellets are designed to release hormone over several months. The actual duration depends on the hormone, dose, absorption, metabolism, symptoms, and laboratory findings. A scheduled reinsertion shouldn't happen automatically if hormone levels remain high or adverse effects are present.
Can a pellet be removed early?
Pellets can't be dissolved or flushed from the body on demand. If a serious problem develops, a clinician may discuss whether surgical removal is appropriate, but removal is itself a procedure and isn't a substitute for careful initial dosing.
What happens if the dose is too high?
Excess exposure may cause acne, facial or body hair growth, hair loss, mood changes, voice deepening, clitoral enlargement, vaginal bleeding, or increased hematocrit. Some androgenic effects can be irreversible, which is why patients should contact their provider promptly rather than waiting for the next routine insertion.
The most balanced answer to the hormone pellets pros and cons question is that pellets may be convenient for selected patients who have a clear indication, understand the limited reversibility, and can complete structured follow-up. They aren't automatically safer because they're bioidentical, and they shouldn't be marketed as a universal answer for fatigue, weight concerns, aging, or nonspecific symptoms.
Aspire for Wellness Together provides individualized hormone evaluations and treatment planning for men and women in Bradenton and surrounding Gulf Coast communities, with recommendations based on medical history, symptoms, laboratory findings, medications, risk factors, and health goals. Visit Aspire for Wellness Together to request an evaluation and discuss whether pellets or a more adjustable hormone-delivery option fits your situation.